ARTICLE | Strategy
Roche’s partnering priority
Why Roche’s new combined partnering team will likely focus first on near-term growth drivers
July 13, 2018 9:52 PM UTC
As James Sabry gets set to lead partnering for all of Roche pharma, his first order of business might be to build out the company’s late-stage pipeline ahead of an impending patent cliff that puts nearly half its revenues at risk.
Sabry has served as head of partnering for Genentech Research and Early Development (gRED) since 2010, a role that has focused on deals for early stage products and technologies for Roche’s Genentech Inc. unit...